Chemical inhibitors of 1190002N15Rik can be understood through their actions on various cellular signaling pathways that are related to the function of this protein. LY294002 and Wortmannin target the PI3K/AKT signaling pathway, which is a crucial signal transduction pathway that regulates processes such as glucose metabolism, apoptosis, cell proliferation, transcription, and cell migration. The inhibition of PI3K by these chemicals disrupts the activation of AKT, leading to a disruption of any downstream effects that PI3K/AKT pathway may have on the function of 1190002N15Rik. Rapamycin further extends this inhibition to the mTOR pathway, a downstream target of AKT, which is involved in cell growth and proliferation, thus further inhibiting processes that may be regulated by 1190002N15Rik.
In addition to these, PD98059 and U0126 inhibit the MEK1/2, key components of the ERK pathway. This inhibition prevents the activation of ERK, a critical mediator of cell division, which may be linked to the function of 1190002N15Rik. SB203580 and SP600125 inhibit the p38 MAPK and JNK pathways, respectively, both of which are involved in responses to stress stimuli, including inflammatory cytokines and ultraviolet irradiation. The inhibition of these MAP kinases can alter the cell's response to stress, which can inhibit the functional role of 1190002N15Rik in these pathways. Dasatinib and PP2 inhibit Src family kinases, which participate in various signaling pathways that control cell proliferation, differentiation, migration, and survival, all of which could influence the function of 1190002N15Rik. Bisindolylmaleimide I targets PKC, which regulates numerous cellular responses such as gene expression, protein secretion, cell proliferation, and the inflammatory response, leading to an inhibition of 1190002N15Rik's function within these processes. Lastly, Staurosporine and Lapatinib inhibit a broad spectrum of kinases and the EGFR/HER2 tyrosine kinases, respectively, impeding signaling pathways that may interact with or regulate 1190002N15Rik, thereby inhibiting its function in the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which is involved in the AKT signaling pathway potentially connected to the function of 1190002N15Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Acts on PI3K, similarly inhibiting the AKT pathway, which could lead to functional inhibition of 1190002N15Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a downstream component of the PI3K/AKT pathway, which can result in functional inhibition of 1190002N15Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK1/2, thereby potentially inhibiting ERK pathway signaling and the function of 1190002N15Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Targets MEK1/2, preventing ERK pathway activation, potentially inhibiting the function of 1190002N15Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially disrupting signaling pathways involving 1190002N15Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which may lead to functional inhibition of signaling pathways involving 1190002N15Rik. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src family kinase inhibitor, possibly leading to the functional inhibition of related signaling pathways involving 1190002N15Rik. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, which may result in functional inhibition of 1190002N15Rik through related signaling pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits PKC, which could lead to functional inhibition of 1190002N15Rik. | ||||||